You need to be logged in to view this video
Small-cap biotech is not affected by the economy and ignored by the institutions and computerized algo traders. You must Be early, be right, and hold on to turn every $1 into $20 over the next few years. Join this session to learn Michael Murphys three early biotech stock picks. Its his job to be right about the science and getting FDA approval. Its your job to hold on until its time to cash in.
Michael Murphy
New World Investor,
Editor
Michael Murphy, CFA, has been writing technology investment newsletters for 38 years. He has been a security analyst on the buy-side and sell-side, director of research, mutual fund manager, hedge fund manager, venture capitalist, and CEO of a software company. For the very difficult market in the five years 2008-2012, Mr. Murphy's New World Investor newsletter was rated #1 by The Hulbert Financial Digest.
Trending Now
Filter By Category
Filter By Keywords
Loading...